This study investigates pancreatic ductal adenocarcinoma. The purpose of this study is to explore ways to detect this condition early and prevent its development.
The study focuses on gathering information to understand better the safety and effectiveness of early detection methods for pancreatic cancer. It evaluates various factors that may help in identifying the condition at an earlier stage.
- Who can participate: Individuals aged 35 and older with a family history of pancreatic cancer or specific genetic markers may qualify. Participants include those with certain gene variants or those related to individuals with pancreatic cancer.
- Study details: Participants will provide biosamples such as blood or saliva for research purposes. Some participants may receive a placebo, which is an inactive substance that looks like the investigational medicine but does not contain any medicine.
How understandable was the trial content above?
Hard to understand
Easy to understand